BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,045 filers reported holding BAXTER INTL INC in Q4 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $9,127,000 | -3.7% | 141,197 | -6.5% | 0.14% | -16.0% |
Q3 2017 | $9,477,000 | -46.3% | 151,029 | -48.2% | 0.17% | -55.1% |
Q2 2017 | $17,649,000 | +18.8% | 291,523 | +1.8% | 0.38% | +14.6% |
Q1 2017 | $14,856,000 | +364.1% | 286,466 | +296.8% | 0.33% | +234.7% |
Q4 2016 | $3,201,000 | -35.1% | 72,194 | -30.4% | 0.10% | -46.7% |
Q3 2016 | $4,935,000 | +48.6% | 103,664 | +41.1% | 0.18% | +2.8% |
Q2 2016 | $3,322,000 | +620.6% | 73,456 | +555.0% | 0.18% | +517.2% |
Q1 2016 | $461,000 | +18.2% | 11,215 | +9.7% | 0.03% | -3.3% |
Q4 2015 | $390,000 | +17.5% | 10,224 | +1.0% | 0.03% | -43.4% |
Q3 2015 | $332,000 | -65.3% | 10,119 | -26.1% | 0.05% | +39.5% |
Q2 2015 | $957,000 | -78.1% | 13,694 | -78.5% | 0.04% | -78.2% |
Q1 2015 | $4,365,000 | +186.0% | 63,733 | +206.0% | 0.17% | +120.3% |
Q4 2014 | $1,526,000 | -72.4% | 20,828 | -73.0% | 0.08% | -81.6% |
Q3 2014 | $5,539,000 | – | 77,181 | – | 0.43% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |